The selection of appropriate bacterial strains in preclinical evaluation of infection-resistant biomaterials.
D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity; D018441:Biofilms / Q000187:drug effects / Q000254:growth & development; D020099:Coated Materials, Biocompatible; D024881:Drug Resistance, Bacterial; D004866:Equipment Contamination; D023281:Genomics; D006801:Humans; D017053:Infection Control; D008422:Materials Testing / Q000379:methods; D017720:Molecular Epidemiology; D019736:Prostheses and Implants / Q000009:adverse effects*; D011474:Prosthesis Design; D016459:Prosthesis-Related Infections / Q000382:microbiology / Q000517:prevention & control*; D015203:Reproducibility of Results
D000890:Anti-Infective Agents; D020099:Coated Materials, Biocompatible